1 | 0.9% normal saline (control) | - | - | - | - | [1] 299 299 |
2 | Active Control | - | - | - | - | [1] 13 13 |
3 | Amitriptyline, fluoxetine and tramadol alone (control group) | [3] Amitriptyline Amitriptyline, Fluoxetine, Tramadol | [3] D00326
D00326
,
D07448
,
D08623
| [3] OPRM1 OPRM1, SLC6A2, SLC6A4 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 78 78 |
4 | Boots High Strength Garlic Odour Controlled | [1] Garlic Garlic | [1] D12020
D12020
| - | - | [1] 299 299 |
5 | BPR277 ointment (controlled application) | - | - | - | - | [1] 160 160 |
6 | Carbidopa and Levodopa Controlled Release Tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
7 | Coenzyme Q-10 in Normal Control subjects | [1] Ubidecarenone Ubidecarenone | [1] D01065
D01065
| - | - | [1] 86 86 |
8 | Control | - | - | - | - | [4] 6 6, 46, 168, 299 |
9 | Control gel | - | - | - | - | [1] 36 36 |
10 | Control group | - | - | - | - | [4] 2 2, 13, 46, 70 |
11 | Control Group 0.9% Isotonic Saline | - | - | - | - | [1] 299 299 |
12 | Control intervention (no dexamethasone) | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
13 | Control multivitamin | - | - | - | - | [1] 299 299 |
14 | Controlled-release levodopa / carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
15 | Cornstarch control | [1] Starch, corn Starch, corn (Synonym: Lotrimin Daily Sweat and Odor Control) | [1] D05297
D05297
| - | - | [1] 90 90 |
16 | Diazoxide choline controlled-release tablet | [2] Choline Choline, Diazoxide | [2] D00294
D00294
,
D07690
| [2] ABCC8 ABCC8, KCNJ11 💬 | [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 |
17 | Epilim Chrono 200 Controlled Released tablets | - | - | - | - | [1] 256 256 |
18 | Epilim Chrono 300 Controlled Released tablets | - | - | - | - | [1] 256 256 |
19 | Epilim Chrono 500 Controlled Released tablets | - | - | - | - | [1] 256 256 |
20 | Group 1- Control Diet | - | - | - | - | [1] 97 97 |
21 | High dose vehicle control | - | - | - | - | [1] 46 46 |
22 | Infliximab Control | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
23 | Levodopa CR (controlled release) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
24 | Low dose vehicle control | - | - | - | - | [1] 46 46 |
25 | Ropinirole controlled-release (REQUIP CR) for RLS | [1] Ropinirole Ropinirole | [1] D08489
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
26 | Sinemet® controlled release (Carbidopa/levodopa) | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
27 | Treatment vs control bread | - | - | - | - | [1] 97 97 |
28 | Vehice Control | - | - | - | - | [1] 96 96 |
29 | Vehicle Control | - | - | - | - | [1] 53 53 |